Patents by Inventor Siead I. Zegar

Siead I. Zegar has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 9504672
    Abstract: The present invention provides novel crystalline polymorphic forms of MDT-637, in particular, crystalline polymorphic forms with physicochemical properties specifically suited for drug production, amorphous formation, composite form, and methods of preparation thereof. The novel polymorphs described herein are useful for the treatment of respiratory disease, such as disease caused by respiratory syncytial virus.
    Type: Grant
    Filed: April 10, 2015
    Date of Patent: November 29, 2016
    Assignee: MICRODOSE THERAPEUTX, INC.
    Inventors: Robert O. Cook, Eugene R. Reynolds, Boris Shekunov, Siead I. Zegar
  • Publication number: 20150209328
    Abstract: The present invention provides novel crystalline polymorphic forms of MDT-637, in particular, crystalline polymorphic forms with physicochemical properties specifically suited for drug production, amorphous formation, composite form, and methods of preparation thereof. The novel polymorphs described herein are useful for the treatment of respiratory disease, such as disease caused by respiratory syncytial virus.
    Type: Application
    Filed: April 10, 2015
    Publication date: July 30, 2015
    Applicant: MicroDose Therapeutx, Inc.
    Inventors: Robert O. Cook, Eugene R. Reynolds, Boris Shekunov, Siead I. Zegar
  • Patent number: 9040569
    Abstract: The present invention provides novel crystalline polymorphic forms of MDT-637, in particular, crystalline polymorphic forms with physicochemical properties specifically suited for drug production, amorphous formation, composite form, and methods of preparation thereof. The novel polymorphs described herein are useful for the treatment of respiratory disease, such as disease caused by respiratory syncytial virus.
    Type: Grant
    Filed: June 28, 2013
    Date of Patent: May 26, 2015
    Assignee: MICRODOSE THERAPEUTX
    Inventors: Robert O. Cook, Eugene R. Reynolds, Boris Shekunov, Siead I. Zegar
  • Publication number: 20140005239
    Abstract: The present invention provides novel crystalline polymorphic forms of MDT-637, in particular, crystalline polymorphic forms with physicochemical properties specifically suited for drug production, amorphous formation, composite form, and methods of preparation thereof. The novel polymorphs described herein are useful for the treatment of respiratory disease, such as disease caused by respiratory syncytial virus.
    Type: Application
    Filed: June 28, 2013
    Publication date: January 2, 2014
    Inventors: Robert O. Cook, Eugene R. Reynolds, Boris Shekunov, Siead I. Zegar
  • Patent number: 7579483
    Abstract: The present invention involves a process for preparing substituted indoles, such as DTSI involving two sequential cross-coupling reactions.
    Type: Grant
    Filed: May 15, 2007
    Date of Patent: August 25, 2009
    Assignee: deCODE Genetics, ehf.
    Inventors: Jasbir Singh, Siead I. Zegar, David E. Zembower, Christopher J. Tokar, Livia A. Enache, Wayne E. Zeller
  • Publication number: 20070270594
    Abstract: The present invention involves a process for preparing substituted indoles, such as DTSI involving two sequential cross-coupling reactions.
    Type: Application
    Filed: May 15, 2007
    Publication date: November 22, 2007
    Applicant: DECODE GENETICS, EHF.
    Inventors: Jasbir Singh, Siead I. Zegar, David E. Zembower, Christopher J. Tokar, Livia A. Enache, Wayne E. Zeller